Pneumococcal conjugate vaccine use during humanitarian crises (Q90337288)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

review article

1 reference

title

Pneumococcal conjugate vaccine use during humanitarian crises (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

pneumococcal conjugate vaccine

12 April 2020

main subject

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

Olivier le Polain de Waroux

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Stefan Flasche

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Kim Mulholland

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Francesco Checchi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Emma Diggle

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

Kartini Gadroen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

V Bhargavi Rao

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

publication date

24 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

number of pages

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

page(s)

6787-6792

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

The public health aspects of complex emergencies and refugee situations

12 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Excess mortality in refugees, internally displaced persons and resident populations in complex humanitarian emergencies (1998-2012) - insights from operational data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

7 January 2021

Displacement and health

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Public health information in crisis-affected populations: a review of methods and their use for advocacy and action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Outbreak of Pneumococcal Meningitis, Paoua Subprefecture, Central African Republic, 2016-2017

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Seasonal upsurge of pneumococcal meningitis in the Central African Republic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

The burden of acute respiratory infections in crisis-affected populations: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

outbreaks and implications for transmission and control: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Risk factors for community-acquired pneumonia in children under five years of age in the post-pneumococcal conjugate vaccine era in Brazil: a case control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

The epidemiology of acute respiratory tract infection in young children: comparison of findings from several developing countries. Coordinated Data Group of BOSTID Researchers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Invasive pneumococcal pneumonia and respiratory virus co-infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Increased childhood morbidity after measles is short-term in urban Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Prevalence, determinants, and molecular epidemiology of Streptococcus pneumoniae isolates colonizing the nasopharynx of healthy children in Rome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Sustaining pneumococcal vaccination after transitioning from Gavi support: a modelling and cost-effectiveness study in Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Mathematical modelling long-term effects of replacing Prevnar7 with Prevnar13 on invasive pneumococcal diseases in England and Wales

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

The Efficacy and Duration of Protection of Pneumococcal Conjugate Vaccines Against Nasopharyngeal Carriage: A Meta-regression Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Historical and regulatory perspectives on the treatment effect of antibacterial drugs for community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

What can we learn from the time course of untreated and partially treated community-onset Streptococcus pneumoniae pneumonia? A clinical perspective on superiority and noninferiority trial designs for mild community-acquired pneumonia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Impact of antimicrobial therapy on nasopharyngeal carriage of Streptococcus pneumoniae, Haemophilus influenzae, and Branhamella catarrhalis in children with respiratory tract infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Risk factors for community-acquired pneumonia among adults in Kenya: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Indoor air pollution from unprocessed solid fuel use and pneumonia risk in children aged under five years: a systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Risk Factors for Pneumococcal Colonization of the Nasopharynx in Alaska Native Adults and Children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Predictors of pneumococcal carriage and the effect of the 13-valent pneumococcal conjugate vaccination in the Western Australian Aboriginal population.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Herd protection induced by pneumococcal conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Direct and Indirect Effects of PCV13 on Nasopharyngeal Carriage of PCV13 Unique Pneumococcal Serotypes in Massachusetts’ Children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross-sectional carriage studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Cost-effectiveness and economic benefits of vaccines in low- and middle-income countries: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Vaccine-preventable disease and the under-utilization of immunizations in complex humanitarian emergencies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Approaches to Vaccination Among Populations in Areas of Conflict

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Assessing the efficiency of catch-up campaigns for the introduction of pneumococcal conjugate vaccine: a modelling study based on data from PCV10 introduction in Kilifi, Kenya

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Pneumonia Prevention during a Humanitarian Emergency: Cost-effectiveness of Haemophilus Influenzae Type B Conjugate Vaccine and Pneumococcal Conjugate Vaccine in Somalia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Pneumonia prevention: Cost-effectiveness analyses of two vaccines among refugee children aged under two years, Haemophilus influenzae type b-containing and pneumococcal conjugate vaccines, during a humanitarian emergency, Yida camp, South Sudan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Evidence on public health interventions in humanitarian crises

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

A post-conflict vaccination campaign, Central African Republic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Strengthening the evidence base for health programming in humanitarian crises.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Pneumococcal conjugate vaccine 13 delivered as one primary and one booster dose (1 + 1) compared with two primary doses and a booster (2 + 1) in UK infants: a multicentre, parallel group randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Immunogenicity and reactogenicity of ten-valent versus 13-valent pneumococcal conjugate vaccines among infants in Ho Chi Minh City, Vietnam: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Ethics of research in refugee populations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

The Long-Term Safety, Public Health Impact, and Cost-Effectiveness of Routine Vaccination with a Recombinant, Live-Attenuated Dengue Vaccine (Dengvaxia): A Model Comparison Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Predicting the impact of pneumococcal conjugate vaccine programme options in Vietnam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Real-time analysis of the diphtheria outbreak in forcibly displaced Myanmar nationals in Bangladesh

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

The potential impact of case-area targeted interventions in response to cholera outbreaks: A modeling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Reactive and pre-emptive vaccination strategies to control hepatitis E infection in emergency and refugee settings: A modelling study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Identifying transmission routes of Streptococcus pneumoniae and sources of acquisitions in high transmission communities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Association Between the Decline in Pneumococcal Disease in Unimmunized Adults and Vaccine-Derived Protection Against Colonization in Toddlers and Preschool-Aged Children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

The use of quasi-experimental designs for vaccine evaluation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Effect of 10-valent pneumococcal conjugate vaccine on the incidence of radiologically-confirmed pneumonia and clinically-defined pneumonia in Kenyan children: an interrupted time-series analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

Estimating the population-level impact of vaccines using synthetic controls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2019.09.038

10.1016/J.VACCINE.2019.09.038

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json

12 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31562004%20AND%20SRC:MED&resulttype=core&format=json